HPV Genotype Attribution and Disease Burden of Anal Cancer in China
ConditionAnal Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorFudan University
About this trial
To demonstrate HPV prevalence and its genotype distributions in anal cancer in China and to describe demographic and clinical features of HPV-related anal cancer in China; To describe the epidemiological characteristics ,trends and of disease burden of anal cancer in China
Eligibility criteria
Qualifiers
(1) Patients diagnosed with anal cancers, (2) Patients without radiation or chemotherapy prior to specimen collection;
Disqualifiers
(1) Patients with HIV infection, (2) Patients with immunosuppression after solid organ transplantation, (3) Those who do not agree to specimen collection and testing, (4) For retrospective study cases, those who without specimen.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
1Fudan University Shanghai Cancer Center200032, Shanghai China
Sponsors and collaborators
Fudan University
Lead sponsor
Source ClinicalTrials.gov